• Topcon Healthcare’s fully robotic Maestro2 uses artificial intelligence and is available to all GluCare patients
  • Diabetic retinopathy is the leading cause of blindness in working-age adults, affecting one third of diabetics

Dubai: GluCare Integrated Diabetes Center and Topcon Healthcare, a leading developer of diagnostic equipment for the ophthalmic community, are announcing that they have joined forces to introduce the region’s first use of artificial intelligence (AI) in retinal screenings.

Under the partnership, Topcon Healthcare’s fully automated Maestro2 diagnostic hardware will be available to all patients of GluCare as part of their standard care package. The Maestro2 is an advanced optical coherence tomography (OCT) system that uses AI to provide instantaneous diagnostic retinal screenings. The technology was made possible thanks to a partnership between Topcon and Thirona, a tech company that develops automated medical analysis tools.  

The new technology is in line with GluCare’s innovative world-first model of care which uses wearable and connected technology to allow Remote Continuous Data Monitoring as part of its standard care model. The clinic also holds the honour of being the first within the Middle East region to use Digital Therapeutics in a clinical setting.

Diabetic retinopathy is a leading cause of blindness in working-age adults - affecting one third of people with diabetes.[1] Despite this fact, retinal screening is still not offered in many diabetes centers and less than half of diabetic patients undergo regular retinal screenings.

With the WHO estimating that diabetes is set to grow across the region to more than 42 million people by 2030, GluCare’s Co-Founder and Managing Director, Dr Ihsan AlMarzooqi says that employing innovative technology is key for improved patient outcomes, as well as better savings for patients and insurers alike:  

“At GluCare, we employ technology as a humanizing force, enabling and empowering patients to successfully manage their condition. This extends to all stages of the patient journey, from our in-clinic workflows through to the remote and connected care we offer in between their visits. Our partnership with Topcon further bolsters this transformative model of care by making retinal screening accessible to all of our patients, as well as by employing innovative AI-driven technology that is as precise as it is time and cost effective.

Opened in September 2020, GluCare is currently accepting new patients. Insurance providers currently accepted at GluCare include NAS/Neuron, AXA, Al Madallah, Mednet and Nextcare.

For more information on GluCare, visit www.Glucare.Health 


About Glucare Integrated Diabetes Center:

The first diabetes clinic of its kind in the world, GluCare is reinventing diabetes care and transforming lives. Conceptualized in the UAE and opening the doors to its state-of-the-art 10,000 sq foot Dubai clinic in September 2020, it is the world’s first healthcare provider to empower both clinicians and patients through Remote Continuous Data Monitoring as part of its standard model of care, an innovative and highly personalized ‘continuous healthcare’ approach that provides a comprehensive, and real-time view of patients.  As part of its unique model, GluCare is also an early adopter of - and the region’s first clinic to use - Digital Therapeutics (DTx), combining it with wearable and smart technology,  artificial intelligence, unique in-clinic workflows, and a caring and connected expert care team. Applying technology as a humanizing force, GluCare’s team partners with diabetes patients and their families, giving them the tools, knowledge, and continuous support to live longer, healthier, and more fulfilling lives.  www.glucare.health 

Glucare Online

Glucare Contact Details & Opening Hours

  • Tel: +971 04 220 1570
  • Email: info@glucare.health 
  • Address: 268 Al Wasl Road, Dubai, United Arab Emirates (Parking Onsite at Level B)
  • Google Map: Location
  • Hours:
    • Sunday – Thursday: 8am -6pm
    • Friday-Saturday: Closed

For more information or to request interviews or high res images, please contact:
Dawn Barnable
The B Collective for GluCare Integrated Diabetes Center
E: dawnb@thebcollectiveme.com 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.